Genetics of hypertrophic cardiomyopathy: One, two, or more diseases?

J. Martijn Bos, Steve R. Ommen, Michael John Ackerman

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Hypertrophic cardiomyopathy is the most common identifiable cause of sudden death in the young. This review details the history of hypertrophic cardiomyopathy, recent discoveries in its genetic underpinnings and important genotype-phenotype relationships described in recent studies. RECENT FINDINGS: Since the discovery of the genetic underpinnings of hypertrophic cardiomyopathy in 1989 hundreds of mutations scattered among at least 10 sarcomeric genes confer the pathogenetic substrate for this 'disease of the sarcomere/myofilament'. More recently, the genetic spectrum of hypertrophic cardiomyopathy has expanded to encompass mutations in Z-disc-associated genes (Z-disc hypertrophic cardiomyopathy) and glycogen storage diseases mimicking hypertrophic cardiomyopathy (metabolic hypertrophic cardiomyopathy). Recent genotype-phenotype studies have discovered an important relationship between the morphology of the left ventricle, its underlying genetic substrate and the long-term outcome of this disease. SUMMARY: Genomic medicine has entered clinical practice and the diagnostic utility of genetic testing for hypertrophic cardiomyopathy is clearly evident, but with the growing number of hypertrophic cardiomyopathy-associated genes strategic choices have to be made. With recent discoveries in genotype-phenotype relationships, especially pertaining to the echocardiographic septal shape and the underlying pathogenetic mutation, time has come to subdivide the one disease we call hypertrophic cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)193-199
Number of pages7
JournalCurrent Opinion in Cardiology
Volume22
Issue number3
DOIs
StatePublished - May 2007

Fingerprint

Hypertrophic Cardiomyopathy
Genotype
Phenotype
Mutation
Genes
Glycogen Storage Disease
Sarcomeres
Myofibrils
Genetic Testing
Sudden Death
Heart Ventricles
Cause of Death
History
Medicine

Keywords

  • Genetic testing
  • Hypertrophic cardiomyopathy
  • Myofilament
  • Septal morphology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Genetics of hypertrophic cardiomyopathy : One, two, or more diseases? / Bos, J. Martijn; Ommen, Steve R.; Ackerman, Michael John.

In: Current Opinion in Cardiology, Vol. 22, No. 3, 05.2007, p. 193-199.

Research output: Contribution to journalArticle

@article{f93b06f3720c4adfa52fa9aed4602a99,
title = "Genetics of hypertrophic cardiomyopathy: One, two, or more diseases?",
abstract = "PURPOSE OF REVIEW: Hypertrophic cardiomyopathy is the most common identifiable cause of sudden death in the young. This review details the history of hypertrophic cardiomyopathy, recent discoveries in its genetic underpinnings and important genotype-phenotype relationships described in recent studies. RECENT FINDINGS: Since the discovery of the genetic underpinnings of hypertrophic cardiomyopathy in 1989 hundreds of mutations scattered among at least 10 sarcomeric genes confer the pathogenetic substrate for this 'disease of the sarcomere/myofilament'. More recently, the genetic spectrum of hypertrophic cardiomyopathy has expanded to encompass mutations in Z-disc-associated genes (Z-disc hypertrophic cardiomyopathy) and glycogen storage diseases mimicking hypertrophic cardiomyopathy (metabolic hypertrophic cardiomyopathy). Recent genotype-phenotype studies have discovered an important relationship between the morphology of the left ventricle, its underlying genetic substrate and the long-term outcome of this disease. SUMMARY: Genomic medicine has entered clinical practice and the diagnostic utility of genetic testing for hypertrophic cardiomyopathy is clearly evident, but with the growing number of hypertrophic cardiomyopathy-associated genes strategic choices have to be made. With recent discoveries in genotype-phenotype relationships, especially pertaining to the echocardiographic septal shape and the underlying pathogenetic mutation, time has come to subdivide the one disease we call hypertrophic cardiomyopathy.",
keywords = "Genetic testing, Hypertrophic cardiomyopathy, Myofilament, Septal morphology",
author = "Bos, {J. Martijn} and Ommen, {Steve R.} and Ackerman, {Michael John}",
year = "2007",
month = "5",
doi = "10.1097/HCO.0b013e3280e1cc7f",
language = "English (US)",
volume = "22",
pages = "193--199",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Genetics of hypertrophic cardiomyopathy

T2 - One, two, or more diseases?

AU - Bos, J. Martijn

AU - Ommen, Steve R.

AU - Ackerman, Michael John

PY - 2007/5

Y1 - 2007/5

N2 - PURPOSE OF REVIEW: Hypertrophic cardiomyopathy is the most common identifiable cause of sudden death in the young. This review details the history of hypertrophic cardiomyopathy, recent discoveries in its genetic underpinnings and important genotype-phenotype relationships described in recent studies. RECENT FINDINGS: Since the discovery of the genetic underpinnings of hypertrophic cardiomyopathy in 1989 hundreds of mutations scattered among at least 10 sarcomeric genes confer the pathogenetic substrate for this 'disease of the sarcomere/myofilament'. More recently, the genetic spectrum of hypertrophic cardiomyopathy has expanded to encompass mutations in Z-disc-associated genes (Z-disc hypertrophic cardiomyopathy) and glycogen storage diseases mimicking hypertrophic cardiomyopathy (metabolic hypertrophic cardiomyopathy). Recent genotype-phenotype studies have discovered an important relationship between the morphology of the left ventricle, its underlying genetic substrate and the long-term outcome of this disease. SUMMARY: Genomic medicine has entered clinical practice and the diagnostic utility of genetic testing for hypertrophic cardiomyopathy is clearly evident, but with the growing number of hypertrophic cardiomyopathy-associated genes strategic choices have to be made. With recent discoveries in genotype-phenotype relationships, especially pertaining to the echocardiographic septal shape and the underlying pathogenetic mutation, time has come to subdivide the one disease we call hypertrophic cardiomyopathy.

AB - PURPOSE OF REVIEW: Hypertrophic cardiomyopathy is the most common identifiable cause of sudden death in the young. This review details the history of hypertrophic cardiomyopathy, recent discoveries in its genetic underpinnings and important genotype-phenotype relationships described in recent studies. RECENT FINDINGS: Since the discovery of the genetic underpinnings of hypertrophic cardiomyopathy in 1989 hundreds of mutations scattered among at least 10 sarcomeric genes confer the pathogenetic substrate for this 'disease of the sarcomere/myofilament'. More recently, the genetic spectrum of hypertrophic cardiomyopathy has expanded to encompass mutations in Z-disc-associated genes (Z-disc hypertrophic cardiomyopathy) and glycogen storage diseases mimicking hypertrophic cardiomyopathy (metabolic hypertrophic cardiomyopathy). Recent genotype-phenotype studies have discovered an important relationship between the morphology of the left ventricle, its underlying genetic substrate and the long-term outcome of this disease. SUMMARY: Genomic medicine has entered clinical practice and the diagnostic utility of genetic testing for hypertrophic cardiomyopathy is clearly evident, but with the growing number of hypertrophic cardiomyopathy-associated genes strategic choices have to be made. With recent discoveries in genotype-phenotype relationships, especially pertaining to the echocardiographic septal shape and the underlying pathogenetic mutation, time has come to subdivide the one disease we call hypertrophic cardiomyopathy.

KW - Genetic testing

KW - Hypertrophic cardiomyopathy

KW - Myofilament

KW - Septal morphology

UR - http://www.scopus.com/inward/record.url?scp=34147201740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147201740&partnerID=8YFLogxK

U2 - 10.1097/HCO.0b013e3280e1cc7f

DO - 10.1097/HCO.0b013e3280e1cc7f

M3 - Article

C2 - 17413275

AN - SCOPUS:34147201740

VL - 22

SP - 193

EP - 199

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 3

ER -